Immunoprevention of non-viral cancers: challenges and strategies for early intervention. [PDF]
Biswas K+3 more
europepmc +1 more source
Cancer cell membrane‐based nanoparticles (CCM‐NPs) and cancer cell‐derived small extracellular vesicles (CsEVs) are emerging as promising drug delivery systems for targeted cancer treatment. Advances in nanotechnology have paved the way for innovative drug delivery systems that enhance the effectiveness of cancer treatment.
Wei Zhang+4 more
wiley +1 more source
Optimizing HPV vaccine effectiveness: impact of vaccination age and dose schedule on immunogenicity and cervical cancer prevention. [PDF]
Rostami Varnousfaderani M+3 more
europepmc +1 more source
Advances on Albumin‐Based Carriers for Anticancer Drug Delivery
This study systematically classifies the drug delivery modes of albumin by examining the characteristics of its surface‐active groups and internal binding sites. It provides an in‐depth analysis of various drug delivery strategies and their corresponding targeting mechanisms.
Ruoli Zhou+4 more
wiley +1 more source
Loneliness, but not social isolation, is a risk factor for COVID-19 vaccine hesitancy in university students in Tokyo, Japan. [PDF]
Goto Y+8 more
europepmc +1 more source
Chemically modified graphene oxide nanocarriers provide a targeted lung cancer gene therapy platform. In a 3D tumor microenvironment model, these nanocarriers deliver therapeutic genes, regulate immune markers, and induce apoptosis in cancer cells. Combined gene delivery enhances cancer cell elimination, demonstrating the potential of this approach for
Francesca Grilli+3 more
wiley +1 more source
Designing a multi-epitope universal vaccine for concurrent infections of SARS-CoV-2 and influenza viruses using an immunoinformatics approach. [PDF]
Mohammadipour S+4 more
europepmc +1 more source
Mapping the landscape of AI and ML in vaccine innovation: A bibliometric study. [PDF]
Niu J+6 more
europepmc +1 more source
Adverse events affecting recovery from seasonal influenza vaccination in the hypertensive population: A population-based pharmacovigilance analysis. [PDF]
Wu H, He X, Cao Y, Gao W.
europepmc +1 more source